Cargando…

Correction: The K(+) Channel K(Ca)3.1 as a Novel Target for Idiopathic Pulmonary Fibrosis

Detalles Bibliográficos
Autores principales:	Roach, Katy M, Duffy, Stephen Mark, Coward, William, Feghali-Bostwick, Carol, Wulff, Heike, Bradding, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897356/ http://dx.doi.org/10.1371/annotation/790e86f8-3506-49d6-b7d0-7dbbc580d808

Ejemplares similares

The K(+) Channel K(Ca)3.1 as a Novel Target for Idiopathic Pulmonary Fibrosis
por: Roach, Katy Morgan, et al.
Publicado: (2013)

Increased constitutive αSMA and Smad2/3 expression in idiopathic pulmonary fibrosis myofibroblasts is K(Ca)3.1-dependent
por: Roach, Katy M, et al.
Publicado: (2014)

Human lung myofibroblast TGFβ1-dependent Smad2/3 signalling is Ca(2+)-dependent and regulated by K(Ca)3.1 K(+) channels
por: Roach, Katy M, et al.
Publicado: (2015)

K(Ca)3.1 K(+) Channel Expression and Function in Human Bronchial Epithelial Cells
por: Arthur, Greer K., et al.
Publicado: (2015)

Functional K(Ca)3.1 K(+) channels are required for human fibrocyte migration
por: Cruse, Glenn, et al.
Publicado: (2011)

K(Ca)3.1 Channel-Blockade Attenuates Airway Pathophysiology in a Sheep Model of Chronic Asthma
por: Van Der Velden, Joanne, et al.
Publicado: (2013)

Lipoxin A(4) Attenuates Constitutive and TGF-β1–Dependent Profibrotic Activity in Human Lung Myofibroblasts
por: Roach, Katy M., et al.
Publicado: (2015)

Engagement of the EP(2) prostanoid receptor closes the K(+) channel K(Ca)3.1 in human lung mast cells and attenuates their migration
por: Duffy, S Mark, et al.
Publicado: (2008)

Adenosine closes the K(+) channel K(Ca)3.1 in human lung mast cells and inhibits their migration via the adenosine A(2A) receptor
por: Duffy, S Mark, et al.
Publicado: (2007)

Orai/CRACM1 and K(Ca)3.1 ion channels interact in the human lung mast cell plasma membrane
por: Duffy, S. Mark, et al.
Publicado: (2015)

A central role for G9a and EZH2 in the epigenetic silencing of cyclooxygenase-2 in idiopathic pulmonary fibrosis
por: Coward, William R., et al.
Publicado: (2014)

The Ca(2+)-Activated K(+) Channel KCa3.1 as a Potential New Target for the Prevention of Allograft Vasculopathy
por: Chen, Yi-Je, et al.
Publicado: (2013)

Muscle Damage in Dystrophic mdx Mice Is Influenced by the Activity of Ca(2+)-Activated K(Ca)3.1 Channels
por: Morotti, Marta, et al.
Publicado: (2022)

The feeding behaviour of Amyotrophic Lateral Sclerosis mouse models is modulated by the Ca(2+)‐activated K(Ca)3.1 channels
por: Cocozza, Germana, et al.
Publicado: (2021)

A model of human lung fibrogenesis for the assessment of anti-fibrotic strategies in idiopathic pulmonary fibrosis
por: Roach, Katy M., et al.
Publicado: (2018)

Pulmonary Hypertension in Wild Type Mice and Animals with Genetic Deficit in K(Ca)2.3 and K(Ca)3.1 Channels
por: Wandall-Frostholm, Christine, et al.
Publicado: (2014)

Cancer-Associated Intermediate Conductance Ca(2+)-Activated K(+) Channel K(Ca)3.1
por: Mohr, Corinna J., et al.
Publicado: (2019)

K(Ca)2 and K(Ca)3.1 Channels in the Airways: A New Therapeutic Target
por: Orfali, Razan, et al.
Publicado: (2023)

K(Ca)3.1 Channels and Glioblastoma: In Vitro Studies
por: Klumpp, Lukas, et al.
Publicado: (2018)

Novel Phenolic Inhibitors of Small/Intermediate-Conductance Ca(2+)-Activated K(+) Channels, KCa3.1 and KCa2.3
por: Oliván-Viguera, Aida, et al.
Publicado: (2013)

Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis
por: Wang, Xiao Mei, et al.
Publicado: (2006)

Modulation of Cardiovascular Function in Primary Hypertension in Rat by SKA-31, an Activator of K(Ca)2.x and K(Ca)3.1 Channels
por: Kloza, Monika, et al.
Publicado: (2019)

The Trials and Tribulations of Structure Assisted Design of K(Ca) Channel Activators
por: Shim, Heesung, et al.
Publicado: (2019)

K(Ca)3.1 channel blockade attenuates microvascular remodelling in a large animal model of bleomycin-induced pulmonary fibrosis
por: Derseh, Habtamu B., et al.
Publicado: (2019)

Long intergenic non-coding RNAs regulate human lung fibroblast function: Implications for idiopathic pulmonary fibrosis
por: Hadjicharalambous, Marina R., et al.
Publicado: (2019)

Fibroblasts in fibrosis: novel roles and mediators
por: Kendall, Ryan T., et al.
Publicado: (2014)

Identification of Impacted Pathways and Transcriptomic Markers as Potential Mediators of Pulmonary Fibrosis in Transgenic Mice Expressing Human IGFBP5
por: Nguyen, Xinh-Xinh, et al.
Publicado: (2021)

K(Ca)3.1 Channels Confer Radioresistance to Breast Cancer Cells
por: Mohr, Corinna J., et al.
Publicado: (2019)

The Molecular Mechanisms of Systemic Sclerosis-Associated Lung Fibrosis
por: Mouawad, Joe E., et al.
Publicado: (2023)

Histone Deacetylases Enhance Ca(2+)-Activated K(+) Channel K(Ca)3.1 Expression in Murine Inflammatory CD4(+) T Cells
por: Matsui, Miki, et al.
Publicado: (2018)

382 The Role of the IL-6-IGF-II Axis in Systemic Sclerosis-Associated Lung Fibrosis
por: Adewale, Adegboyega Timothy, et al.
Publicado: (2023)

The Role of SOX9 in IGF-II-Mediated Pulmonary Fibrosis
por: Waldrep, Kristy M., et al.
Publicado: (2023)

New Insights on the Voltage Dependence of the K(Ca)3.1 Channel Block by Internal TBA
por: Banderali, Umberto, et al.
Publicado: (2004)

Functional Roles of the Ca(2+)-activated K(+) Channel, KCa3.1, in Brain Tumors
por: D’Alessandro, Giuseppina, et al.
Publicado: (2018)

IGFBP-5 Promotes Fibrosis Independently of Its Translocation to the Nucleus and Its Interaction with Nucleolin and IGF
por: Su, Yunyun, et al.
Publicado: (2015)

Prominence of IL6, IGF, TLR, and Bioenergetics Pathway Perturbation in Lung Tissues of Scleroderma Patients With Pulmonary Fibrosis
por: Renaud, Ludivine, et al.
Publicado: (2020)

Correction to: T cells in idiopathic pulmonary fibrosis: crucial but controversial
por: Deng, Lishan, et al.
Publicado: (2023)

K(Ca)3.1 Channels Promote Cardiac Fibrosis Through Mediating Inflammation and Differentiation of Monocytes Into Myofibroblasts in Angiotensin II–Treated Rats
por: She, Gang, et al.
Publicado: (2018)

Synthesis and biological evaluation of PET tracers designed for imaging of calcium activated potassium channel 3.1 (K(Ca)3.1) channels in vivo
por: Brömmel, Kathrin, et al.
Publicado: (2021)

Characterization and Chemical Synthesis of Cm39 (α-KTx 4.8): A Scorpion Toxin That Inhibits Voltage-Gated K(+) Channel K(V)1.2 and Small- and Intermediate-Conductance Ca(2+)-Activated K(+) Channels K(Ca)2.2 and K(Ca)3.1
por: Naseem, Muhammad Umair, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_f8amie4lve682bv3ricn7rjbm9